Viewing Study NCT01829035


Ignite Creation Date: 2025-12-24 @ 10:08 PM
Ignite Modification Date: 2026-01-01 @ 9:06 AM
Study NCT ID: NCT01829035
Status: COMPLETED
Last Update Posted: 2018-03-29
First Post: 2013-03-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCC
Sponsor: National Cancer Center, Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module